Event · Zurich

Experience as a Medicine – Pharma AI Executive Breakfast, Zurich

Invitation-only breakfasts at citizenM Zurich where Richard Schwartz showed why experience and trust decide pharma launch success.

Christian Fillinger, Richard Schwartz and Michal Myszkowski

Watch the full webinar

Enter your work email and the full recording opens right here. The slides are in the sidebar.

Oops! Something went wrong while submitting the form.

Experience as a Medicine was a series of invitation-only executive breakfasts that Capptoo Group and Screver hosted at citizenM Zurich on 3–5 February 2026. Up to eight senior pharma leaders per morning discussed how AI, trust and experience decide whether a product launch succeeds, with a keynote by Richard Schwartz.

"Our perceptions change our physiological response to treatment – they shape our biology." – Richard Schwartz

Richard Schwartz: pharma competes on experience, not only on molecules

Richard Schwartz – Health + Care customer experience evangelist (Rx4CX) and member of the Harvard Business Review Advisory Council – argued that pharma no longer competes only on molecules, but on experience, trust and sentiment. In his view, experience is a leading indicator for prescription, adherence and brand preference. The keynote covered:

  • Why experience is a competitive choice in pharma
  • AI's role in enabling – or destroying – trust
  • What pharma gets wrong about AI today
  • Experience as a strategic asset and a "biomarker"

Breakfast agenda

  • 09:00 – arrival and breakfast
  • 09:30 – welcome and framing by Christian Fillinger, CEO & Founder of Capptoo Group: AI, launches and experience
  • 09:40 – keynote: Experience as a Medicine, by Richard Schwartz
  • 10:20 – executive discussion on AI, launch failures and experience gaps
  • 10:50 – launch intelligence: what "Launch IQ" means when feedback, experience and AI are connected
  • 11:25 – closing and follow-ups

AI, trust and pharma launch success: what leaders discussed

  • Treating experience as a strategic asset, not a soft metric
  • Connecting feedback, experience and AI to predict launch outcomes
  • What pharma gets wrong about AI – and how to get it right
  • Why trust and sentiment are becoming competitive advantages

Hosts: Christian Fillinger and Michal Myszkowski

Christian Fillinger, CEO & Founder of Capptoo Group, and Michal Myszkowski of Capptoo Group hosted the breakfasts and led the peer discussion. The format was a thought-leadership exchange among peers, not a sales pitch.

Experience data in pharma launches with Screver

Screver is a Swiss Voice of Customer and Voice of Employee platform and part of Capptoo Group. Pharma teams use Screver to measure HCP and patient experience and act on it – the kind of experience data the breakfasts treated as a leading indicator. Richard Schwartz also spoke at The AI & CX Hype Bubble in Zurich in June 2025.

Frequently asked questions

Where did Experience as a Medicine take place?

At citizenM Zurich, in the city centre of Zurich, Switzerland.

How many guests were at each breakfast?

Up to eight senior pharma executives per morning. The session on 5 February 2026 was fully booked.

Was it a sales event?

No. Capptoo Group and Screver designed the breakfasts as a peer exchange on experience, trust and AI in pharma launches.

Source: event page pharma-ai-breakfast.lovable.app. Last updated: 18 November 2026.